Literature DB >> 12738606

The Sarcoidosis Health Questionnaire: a new measure of health-related quality of life.

Christopher E Cox1, James F Donohue, Cynthia D Brown, Yash P Kataria, Marc A Judson.   

Abstract

The Sarcoidosis Health Questionnaire (SHQ) is a health-related quality-of-life (HRQL) instrument we designed in a two-part study to allow patients to describe their satisfaction with life as it is affected by sarcoidosis. In the Development Study, we created the SHQ from a 151-item pool generated from interviews with 107 patients, a search of the relevant literature, and discussion with sarcoidosis experts. Using clinical impact methodology and the questionnaire responses of a separate group of 149 patients, we reduced the total number of items to 29. The final SHQ has three domains: Daily Functioning, Physical Functioning, and Emotional Functioning. In the Validation Study, performed with a different group of 111 patients, we found that the SHQ had good internal consistency reliability, as well as evidence of content, criterion, and construct validity based on its comparison with other measures of HRQL (Medical Outcomes Study 36-Item short form and the St. George's Respiratory Questionnaire) and of mental health (the Center for Epidemiologic Study-Depression Scale), as well as with clinical variables including spirometry. The SHQ alone was sensitive to differences in HRQL based on the number of involved organ systems. In conclusion, we have developed a self-completed HRQL questionnaire for U.S. patients with sarcoidosis.

Entities:  

Mesh:

Year:  2003        PMID: 12738606     DOI: 10.1164/rccm.200211-1343OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  24 in total

1.  Quality of life in sarcoidosis: comparing the impact of ocular and non-ocular involvement of the disease.

Authors:  Leorey N Saligan; Grace Levy-Clarke; Tongtong Wu; Lisa J Faia; Keith Wroblewski; Steven Yeh; Robert B Nussenblatt; H Nida Sen
Journal:  Ophthalmic Epidemiol       Date:  2010-08       Impact factor: 1.648

2.  Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status.

Authors:  M A Spruit; M J Thomeer; R Gosselink; T Troosters; A Kasran; A J T Debrock; M G Demedts; M Decramer
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

Review 3.  Patient reported outcome measures (PROMs) in sarcoidosis.

Authors:  Rikke Flor Thunold; Anders Løkke; Adam Langballe Cohen; Hilberg Ole; Elisabeth Bendstrup
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

4.  Repository corticotropin injection (H.P. Acthar gel) for the treatment of sarcoidosis-induced hypercalciuria and vitamin D dysregulation: a pilot, open label study.

Authors:  Marc A Judson; Aakash Modi; Furqan Ilyas; Recai Yucel
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

5.  The indications for the treatment of sarcoidosis: Wells Law.

Authors:  Robert P Baughman; Marc A Judson; Athol Wells
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

6.  Development and testing of item response theory-based item banks and short forms for eye, skin and lung problems in sarcoidosis.

Authors:  David E Victorson; Seung Choi; Marc A Judson; David Cella
Journal:  Qual Life Res       Date:  2013-11-09       Impact factor: 4.147

7.  DNA Methylation Changes in Lung Immune Cells Are Associated with Granulomatous Lung Disease.

Authors:  Ivana V Yang; Iain Konigsberg; Kristyn MacPhail; Li Li; Elizabeth J Davidson; Peggy M Mroz; Nabeel Hamzeh; May Gillespie; Lori J Silveira; Tasha E Fingerlin; Lisa A Maier
Journal:  Am J Respir Cell Mol Biol       Date:  2019-01       Impact factor: 6.914

8.  Reliability and convergent validity of the cutaneous sarcoidosis activity and morphology instrument for assessing cutaneous sarcoidosis.

Authors:  Misha Rosenbach; Howa Yeung; Emily Y Chu; Ellen J Kim; Aimee S Payne; Junko Takeshita; Carmela C Vittorio; Karolyn A Wanat; Victoria P Werth; Joel M Gelfand
Journal:  JAMA Dermatol       Date:  2013-05       Impact factor: 10.282

9.  A conceptual model of health-related quality of life in sarcoidosis.

Authors:  David E Victorson; David Cella; Heidi Grund; Marc A Judson
Journal:  Qual Life Res       Date:  2013-05-26       Impact factor: 4.147

Review 10.  Sarcoidosis: an update for the primary care physician.

Authors:  Oluranti A Aladesanmi
Journal:  MedGenMed       Date:  2004-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.